Protopine and allocryptopine increase mRNA levels of cytochromes P450 1A in human hepatocytes and HepG2 cells independently of AhR

Toxicology Letters

Volumn 203, Issue 2, 2011, Pages 135-141

  Vrba, Jiri ^a   Vrublova, Eva ^a   Modriansky, Martin ^a   Ulrichova, Jitka ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Allocryptopine; Aryl hydrocarbon receptor; Cytochrome P450; Gene expression; Human hepatocytes; Protopine

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ALKALOID; ALLOCRYPTOPINE; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; MESSENGER RNA; PROTOPINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BENZOPHENANTHRIDINES; BERBERINE ALKALOIDS; BLOTTING, WESTERN; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; HEP G2 CELLS; HUMANS; LIVER; MALE; MIDDLE AGED; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

FUMARIA OFFICINALIS;

EID: 79955484651     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.03.015     Document Type: Article

References (29)

1. Anzenbacher P., Anzenbacherova E. Cytochromes P450 and metabolism of xenobiotics. Cell. Mol. Life Sci. 2001, 58:737-747.
2. Chang T.K., Waxman D.J. Enzymatic analysis of cDNA-expressed human CYP1A1, CYP1A2, and CYP1B1 with 7-ethoxyresorufin as substrate. Methods Mol. Biol. 1998, 107:103-109.
3. Chou W.M., Kutchan T.M. Enzymatic oxidations in the biosynthesis of complex alkaloids. Plant J. 1998, 15:289-300.
4. Delescluse C., Lemaire G., de Sousa G., Rahmani R. Is CYP1A1 induction always related to AHR signaling pathway?. Toxicology 2000, 153:73-82.
5. Dvorak Z., Vrzal R., Henklova P., Jancova P., Anzenbacherova E., Maurel P., Svecova L., Pavek P., Ehrmann J., Havlik R., Bednar P., Lemr K., Ulrichova J. JNK inhibitor SP600125 is a partial agonist of human aryl hydrocarbon receptor and induces CYP1A1 and CYP1A2 genes in primary human hepatocytes. Biochem. Pharmacol. 2008, 75:580-588.
6. Fan Z.C., Xie C.J., Zhang Z.Q. Simultaneous quantitation of tetrahydropalmatine and protopine in rabbit plasma by HPLC-PAD, and application to pharmacokinetic studies. Chromatographia 2006, 64:577-581.
7. Isom H.C., Secott T., Georgoff I., Woodworth C., Mummaw J. Maintenance of differentiated rat hepatocytes in primary culture. Proc. Natl. Acad. Sci. U.S.A. 1985, 82:3252-3256.
8. ATP channel subunits expressed in HEK-293 cells. Eur. J. Pharmacol. 2004, 506:93-100.
9. Karp J.M., Rodrigo K.A., Pei P., Pavlick M.D., Andersen J.D., McTigue D.J., Fields H.W., Mallery S.R. Sanguinarine activates polycyclic aromatic hydrocarbon associated metabolic pathways in human oral keratinocytes and tissues. Toxicol. Lett. 2005, 158:50-60.
10. 2+-channel blockade in rat thoracic aorta by protopine isolated from Corydalis tubers. Jpn. J. Pharmacol. 1992, 58:1-9.
11. Lemaire G., Delescluse C., Pralavorio M., Ledirac N., Lesca P., Rahmani R. The role of protein tyrosine kinases in CYP1A1 induction by omeprazole and thiabendazole in rat hepatocytes. Life Sci. 2004, 74:2265-2278.
12. Ma H., Wang Y., Guo T., He Z., Chang X., Pu X. Simultaneous determination of tetrahydropalmatine, protopine, and palmatine in rat plasma by LC-ESI-MS and its application to a pharmacokinetic study. J. Pharm. Biomed. Anal. 2009, 49:440-446.
13. Monostory K., Pascussi J.M., Kobori L., Dvorak Z. Hormonal regulation of CYP1A expression. Drug Metab. Rev. 2009, 41:547-572.
14. Moon Y.J., Wang X., Morris M.E. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol. In Vitro 2006, 20:187-210.
15. Morel Y., Barouki R. Down-regulation of cytochrome P450 1A1 gene promoter by oxidative stress. Critical contribution of nuclear factor 1. J. Biol. Chem. 1998, 273:26969-26976.
16. Paul L.D., Springer D., Staack R.F., Kraemer T., Maurer H.H. Cytochrome P450 isoenzymes involved in rat liver microsomal metabolism of californine and protopine. Eur. J. Pharmacol. 2004, 485:69-79.
17. Pichard-Garcia L., Gerbal-Chaloin S., Ferrini J.B., Fabre J.M., Maurel P. Use of long-term cultures of human hepatocytes to study cytochrome P450 gene expression. Methods Enzymol. 2002, 357:311-321.
18. Rathi A., Srivastava A.K., Shirwaikar A., Singh Rawat A.K., Mehrotra S. Hepatoprotective potential of Fumaria indica Pugsley whole plant extracts, fractions and an isolated alkaloid protopine. Phytomedicine 2008, 15:470-477.
19. Saeed S.A., Gilani A.H., Majoo R.U., Shah B.H. Anti-thrombotic and anti-inflammatory activities of protopine. Pharmacol. Res. 1997, 36:1-7.
20. Salminen K.A., Meyer A., Jerabkova L., Korhonen L.E., Rahnasto M., Juvonen R.O., Imming P., Raunio H. Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids. Phytomedicine 2010, 10.1016/j.phymed.2010.08.012.
21. Satou T., Koga M., Matsuhashi R., Koike K., Tada I., Nikaido T. Assay of nematocidal activity of isoquinoline alkaloids using third-stage larvae of Strongyloides ratti and S. venezuelensis. Vet. Parasitol. 2002, 104:131-138.
22. Shimada T., Fujii-Kuriyama Y. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci. 2004, 95:1-6.
23. Song L.S., Ren G.J., Chen Z.L., Chen Z.H., Zhou Z.N., Cheng H. Electrophysiological effects of protopine in cardiac myocytes: inhibition of multiple cation channel currents. Br. J. Pharmacol. 2000, 129:893-900.
24. Vacek J., Walterova D., Vrublova E., Simanek V. The chemical and biological properties of protopine and allocryptopine. Heterocycles 2010, 81:1773-1789.
25. Wang G.X., Zhou Z., Jiang D.X., Han J., Wang J.F., Zhao L.W., Li J. In vivo anthelmintic activity of five alkaloids from Macleaya microcarpa (Maxim) Fedde against Dactylogyrus intermedius in Carassius auratus. Vet. Parasitol. 2010, 171:305-313.
26. Wilkening S., Stahl F., Bader A. Comparison of primary human hepatocytes and hepatoma cell line HepG2 with regard to their biotransformation properties. Drug Metab. Dispos. 2003, 31:1035-1042.
27. 2+ antagonism and antioxidant mechanisms. Eur. J. Pharmacol. 2008, 591:21-27.
28. Yoshinari K., Ueda R., Kusano K., Yoshimura T., Nagata K., Yamazoe Y. Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements. Biochem. Pharmacol. 2008, 76:139-145.
29. Zdarilova A., Vrzal R., Rypka M., Ulrichova J., Dvorak Z. Investigation of sanguinarine and chelerythrine effects on CYP1A1 expression and activity in human hepatoma cells. Food Chem. Toxicol. 2006, 44:242-249.